Q-omics provides the consensus-scored RNU6-1239P profile across patient tissues and cancer cell-line models. Additionally, RNU6-1239P RNA expression shows 48 significant gene co-expression associations, with the highest sampling consensus in OV.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-1239P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

Locus: 14q11.2 &middot; RNA, U6 small nuclear 1239, pseudogene
External: <a href="https://www.ncbi.nlm.nih.gov/gene/106481571" target="_blank" rel="noopener" class="lin">NCBI Gene &middot; <a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000212612" target="_blank" rel="noopener" class="lin">Ensembl

This table shows molecular features associated with RNU6-1239P in patient tissues and cancer cell lines. In patient samples, RNU6-1239P shows the broadest associations at the RNA and protein expression levels, with OV recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	48	OV (48)	view →